STML
Alkeon Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-650,500
| Closed | -$3.15M | – | 151 |
|
|
2020
Q1 | $3.15M | Sell |
650,500
-175,000
| -21% | -$847K | 0.01% | 104 |
|
|
2019
Q4 | $8.78M | Hold |
825,500
| – | – | 0.03% | 82 |
|
|
2019
Q3 | $8.59M | Buy |
825,500
+615,000
| +292% | +$6.4M | 0.03% | 87 |
|
|
2019
Q2 | $3.23M | Buy |
210,500
+55,500
| +36% | +$850K | 0.01% | 106 |
|
|
2019
Q1 | $1.99M | Buy |
155,000
+85,000
| +121% | +$1.09M | 0.01% | 95 |
|
|
2018
Q4 | $665K | Buy |
70,000
+30,000
| +75% | +$285K | ﹤0.01% | 83 |
|
|
2018
Q3 | $664K | Buy |
+40,000
| New | +$664K | ﹤0.01% | 90 |
|